Prenetics Global Limited ( PRE) - Key Metrics
PRE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.69 | -$0.52 | -$0.90 | $0 |
| 2026Q1 | $2.12 | -$1.36 | -$0.71 | -$0.71 |
| 2025Q4 | $2.28 | -$1.75 | -$1.36 | -$1.37 |
| 2025Q3 | $1.70 | -$0.53 | $0 | $0 |
| 2025Q2 | $1.33 | -$0.94 | $0 | $0 |
PRE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.19 |
| 2026Q1 | 0% | -3.55 |
| 2025Q4 | 0% | -2.25 |
| 2025Q3 | 0% | -6.27 |
| 2025Q2 | 0% | -2.27 |
PRE
Price: $25.44
52 week price:
Earnings Per Share: -3.46 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: Hong Kong
Volume: 162600
Market Capitalization: 432.5 million